Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
1–10 of 23 posts
Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#2Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#3There's also ongoing clinical trials of the drug in China.
Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#4Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#5The full title is: "Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease."
What this is is a study performed in mice, trying to work out the mechanism of action of Remdesivir, which is known to inhibit SARS-CoV-2 in vitro.
What's going to be really interesting is what comes out of ongoing clinical studies: https://www.gilead.com/purpose/advancing-global-health/covid...
Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#6Anyone with actual knowledge know the state of ACE2 inhibitor and chloroquinine efficacy?
https://www.stephenharrodbuhner.com/wp-content/uploads/2020/...
Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#7Anyone with actual knowledge know the state of ACE2 inhibitor and chloroquinine efficacy?
And since China seems to be light years ahead of CDC/FDA, I'm inclined to believe them.
Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#8Re: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) (2018)
#9At first glance I interpreted that it was directly tested on the current strain.